Portfolio (Quarterly)
Guide ↗
Alphabet Inc.
· CIK 0001652044| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | VERA | VERA THERAPEUTICS INC | Healthcare | 241,264.0 | $7.0M | 0.29% | NEW | — | $29.06 | +15.8% |
| 22 | LYEL | LYELL IMMUNOPHARMA INC | Healthcare | 293,256.0 | $4.8M | 0.20% | NEW | — | $16.24 | -16.9% |
| 23 | FHTX | FOGHORN THERAPEUTICS INC | Healthcare | 500,901.0 | $2.4M | 0.10% | NEW | — | $4.89 | -14.5% |
| 24 | WGS | GENEDX HOLDINGS CORP | Healthcare | 22,711.0 | $2.4M | 0.10% | NEW | — | $107.74 | -43.4% |
| 25 | TSHA | TAYSHA GENE THERAPIES INC | Healthcare | 640,882.0 | $2.1M | 0.09% | NEW | — | $3.27 | +74.6% |
| 26 | TCRX | TSCAN THERAPEUTICS INC | Healthcare | 1,077,080.0 | $2.0M | 0.08% | NEW | — | $1.82 | -49.9% |
| 27 | — | BARINTHUS BIOTHERAPEUTICS PL | — | 1,513,644.0 | $1.9M | 0.08% | NEW | — | $1.25 | — |
| 28 | SPRO | SPERO THERAPEUTICS INC | Healthcare | 889,979.0 | $1.7M | 0.07% | NEW | — | $1.88 | +51.6% |
| 29 | TNYA | TENAYA THERAPEUTICS INC | Healthcare | 915,705.0 | $1.5M | 0.06% | NEW | — | $1.62 | -56.1% |
| 30 | HYPR | HYPERFINE INC | Healthcare | 898,720.0 | $1.3M | 0.05% | NEW | — | $1.45 | -6.2% |
| 31 | — | EXACT SCIENCES CORP | — | 23,205.0 | $1.3M | 0.05% | NEW | — | $54.71 | — |
| 32 | AUTL | AUTOLUS THERAPEUTICS PLC | Healthcare | 698,262.0 | $1.1M | 0.05% | NEW | — | $1.63 | -4.3% |
| 33 | GUTS | FRACTYL HEALTH INC | Healthcare | 662,584.0 | $1.1M | 0.04% | NEW | — | $1.59 | -46.5% |
| 34 | ALEC | ALECTOR INC | Healthcare | 175,866.0 | $521K | 0.02% | NEW | — | $2.96 | -48.3% |
| 35 | — | QUINCE THERAPEUTICS INC | — | 189,122.0 | $308K | 0.01% | NEW | — | $1.63 | — |
| 36 | FULC | FULCRUM THERAPEUTICS INC | Healthcare | 14,262.0 | $131K | 0.01% | NEW | — | $9.20 | -62.5% |
| 37 | RGEN | REPLIGEN CORP | Healthcare | 383.0 | $51K | 0.00% | NEW | — | $133.67 | -2.3% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Technology
52.2%
Healthcare
28.7%
Industrials
19.1%